Comparison of markers of oxidative stress, inflammation and arterial stiffness between incident hemodialysis and peritoneal dialysis patients -an observational study

详细信息    查看全文

• 作者：Robert G Fassett (1) (2) (4) (5)
  Ritza Driver (2)
  Helen Healy (1)
  Dwarakanathan Ranganathan (1)
  Sharad Ratanjee (1)
  Iain K Robertson (3)
  Dominic P Geraghty (3)
  James E Sharman (4) (5)
  Jeff S Coombes (2) (4)
  
• 刊名：BMC Nephrology
• 出版年：2009
• 出版时间：December 2009
• 年：2009
• 卷：10
• 期：1
• 全文大小：653KB
• 参考文献：1. Himmelfarb J, Hakim RM: Oxidative stress in uremia. / Curr Opin Nephrol Hypertens 2003,12(6): 593-98. CrossRef
  2. Stenvinkel P: Inflammation in end-stage renal disease: the hidden enemy. / Nephrology (Carlton) 2006,11(1): 36-1. CrossRef
  3. Gusbeth-Tatomir P, Covic A: Causes and consequences of increased arterial stiffness in chronic kidney disease patients. / Kidney Blood Press Res 2007,30(2): 97-07. CrossRef
  4. Segall L, Covic A: Cardiovascular disease in haemodialysis and peritoneal dialysis: arguments pro haemodialysis. / Nephrol Dial Transplant 2007,22(1): 59-3. CrossRef
  5. Van Biesen W, Verbeke F, Vanholder R: Cardiovascular disease in haemodialysis and peritoneal dialysis: arguments pro peritoneal dialysis. / Nephrol Dial Transplant 2007,22(1): 53-8. CrossRef
  6. Jaar BG, Coresh J, Plantinga LC, Fink NE, Klag MJ, Levey AS, Levin NW, Sadler JH, Kliger A, Powe NR: Comparing the risk for death with peritoneal dialysis and hemodialysis in a national cohort of patients with chronic kidney disease. / Ann Intern Med 2005,143(3): 174-83.
  7. Sigrist M, Bungay P, Taal MW, McIntyre CW: Vascular calcification and cardiovascular function in chronic kidney disease. / Nephrol Dial Transplant 2006,21(3): 707-14. CrossRef
  8. Yilmaz FM, Akay H, Duranay M, Yilmaz G, Oztekin PS, Kosar U, Tekeli N, Altay M, Parpucu H, Yucel D: Carotid atherosclerosis and cardiovascular risk factors in hemodialysis and peritoneal dialysis patients. / Clin Biochem 2007,40(18): 1361-366. CrossRef
  9. Blacher J, Guerin AP, Pannier B, Marchais SJ, Safar ME, London GM: Impact of aortic stiffness on survival in end-stage renal disease. / Circulation 1999,99(18): 2434-439.
  10. Sutherland WH, Walker RJ, Ball MJ, Stapley SA, Robertson MC: Oxidation of low density lipoproteins from patients with renal failure or renal transplants. / Kidney Int 1995,48(1): 227-36. CrossRef
  11. Shoskes DA, Shahed AR, Kim S, Gritsch HA, Danovitch G, Wilkinson A: Oxidant stress and antioxidant capacity in urine of renal transplant recipients predict early graft function. / Transplant Proc 2001,33(1-): 984. CrossRef
  12. Paragh G, Asztalos L, Seres I, Balogh Z, Locsey L, Karpati I, Matyus J, Katona E, Harangi M, Kakuk G: Serum paraoxonase activity changes in uremic and kidney-transplanted patients. / Nephron 1999,83(2): 126-31. CrossRef
  13. Ghanem H, Dorpel MA, Weimar W, Man in 'T Veld AJ, El-Kannishy MH, Jansen H: Increased low density lipoprotein oxidation in stable kidney transplant recipients. / Kidney International 1996,49(2): 488-93. CrossRef
  14. Cofan F, Zambon D, Rodriguez C, Laguna JC, Vazquez M, Casals E, Torregrosa J, Ros E, Oppenheimer F: Oxidation of low-density lipoproteins in renal transplant recipients. / Transplantation Proceedings 1999,31(6): 2333-334. CrossRef
  15. Massy ZA, Maziere C, Kamel S, Brazier M, Choukroun G, Tribouilloy C, Slama M, Andrejak M, Maziere JC: Impact of inflammation and oxidative stress on vascular calcifications in chronic kidney disease. / Pediatr Nephrol 2005,20(3): 380-82. CrossRef
  16. Wilkinson IB, Fuchs SA, Jansen IM, Spratt JC, Murray GD, Cockcroft JR, Webb DJ: Reproducibility of pulse wave velocity and augmentation index measured by pulse wave analysis. / J Hypertens 1998,16(12 Pt 2): 2079-084. CrossRef
  17. Mori TA, Croft KD, Puddey IB, Beilin LJ: An improved method for the measurement of urinary and plasma F2-isoprostanes using gas chromatography-mass spectrometry. / Anal Biochem 1999,268(1): 117-25. CrossRef
  18. Rolph MS, Zimmer S, Bottazzi B, Garlanda C, Mantovani A, Hansson GK: Production of the long pentraxin PTX3 in advanced atherosclerotic plaques. / Arterioscler Thromb Vasc Biol 2002,22(5): e10-4. CrossRef
  19. Mitchell CK, Aeschlimann SE, Korcarz CE: Carotid intima-media thickness testing: technical considerations. / J Am Soc Echocardiogr 2004,17(6): 690-92. CrossRef
  20. Chodakauskas T: Non-invasive measurement of surrogate markers of atherosclerosis: carotid intima thickness (c-IMT). GE Healthcare 2006.
  21. Stompor T, Krasniak A, Sulowicz W, Dembinska-Kiec A, Janda K, Wojcik K, Tabor B, Kowalczyk-Michalek ME, Zdzienicka A, Janusz-Grzybowska E: Changes in common carotid artery intima-media thickness over 1 year in patients on peritoneal dialysis. / Nephrol Dial Transplant 2005,20(2): 404-12. CrossRef
  22. Aeschlimann SE, Mitchell CK, Korcarz CE: Ultrasound brachial artery reactivity testing: technical considerations. / J Am Soc Echocardiogr 2004,17(6): 697-99. CrossRef
  23. Dalton BS, Fassett RG, Geraghty DP, De Ryke R, Coombes JS: No relationship between low-density lipoproteins and endothelial function in hemodialysis patients. / Int J Cardiol 2005,99(2): 307-14. CrossRef
  24. Lang RM, Bierig M, Devereux RB, Flachskampf FA, Foster E, Pellikka PA, Picard MH, Roman MJ, Seward J, Shanewise JS, / et al.: Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. / J Am Soc Echocardiogr 2005,18(12): 1440-463. CrossRef
  25. Schiller NB, Shah PM, Crawford M, DeMaria A, Devereux R, Feigenbaum H, Gutgesell H, Reichek N, Sahn D, Schnittger I, / et al.: Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms. / J Am Soc Echocardiogr 1989,2(5): 358-67.
  26. Anderson B: Echocardiography The normal Examination and Echocardiographic Measurements. / Fergies / Second Edition 2007.
  27. Sharman JE, Lim R, Qasem AM, Coombes JS, Burgess MI, Franco J, Garrahy P, Wilkinson IB, Marwick TH: Validation of a generalized transfer function to noninvasively derive central blood pressure during exercise. / Hypertension 2006,47(6): 1203-208. CrossRef
  28. Holland DJ, Sacre JW, McFarlane SJ, Coombes JS, Sharman JE: Pulse wave analysis is a reproducible technique for measuring central blood pressure during hemodynamic perturbations induced by exercise. / Am J Hypertens 2008,21(10): 1100-106. CrossRef
  29. Shimizu M, Kario K: Role of the augmentation index in hypertension. / Ther Adv Cardiovasc Dis 2008,2(1): 25-5. CrossRef
  30. Wilkinson IB, Franklin SS, Hall IR, Tyrrell S, Cockcroft JR: Pressure amplification explains why pulse pressure is unrelated to risk in young subjects. / Hypertension 2001,38(6): 1461-466. CrossRef
  31. The pre-publication history for this paper can be accessed here:http://www.biomedcentral.com/1471-2369/10/8/prepub
  
• 作者单位：Robert G Fassett (1) (2) (4) (5)
  Ritza Driver (2)
  Helen Healy (1)
  Dwarakanathan Ranganathan (1)
  Sharad Ratanjee (1)
  Iain K Robertson (3)
  Dominic P Geraghty (3)
  James E Sharman (4) (5)
  Jeff S Coombes (2) (4)
  
  1. Renal Research, Royal Brisbane and Women's Hospital, 4029, Brisbane, Queensland, Australia
  2. Renal Research Tasmania, Launceston General Hospital, 7250, Launceston, Tasmania, Australia
  4. School of Human Movement Studies The University of Queensland, 4072, St Lucia, Queensland, Australia
  5. School of Medicine The University of Queensland, 4072, Queensland, Australia
  3. School of Human Life Sciences University of Tasmania, 7250, Launceston, Tasmania, Australia
  

文摘

Background Patients on peritoneal and hemodialysis have accelerated atherosclerosis associated with an increase in cardiovascular morbidity and mortality. The atherosclerosis is associated with increased arterial stiffness, endothelial dysfunction and elevated oxidative stress and inflammation. The aims of this study are to investigate the effects of peritoneal and hemodialysis on arterial stiffness, vascular function, myocardial structure and function, oxidative stress and inflammation in incident patients with end stage kidney disease. Methods This is an observational study. Eighty stage five CKD patients will be enrolled and followed for one-year. Primary outcome measures will be changes in 1) arterial stiffness measured by aortic pulse wave velocity, 2) oxidative stress assessed by plasma F2 isoprostanes and 3) inflammation measured by plasma pentraxin-3. Secondary outcomes will include additional measures of oxidative stress and inflammation, changes in vascular function assessed using the brachial artery reactivity technique, carotid artery intimal medial thickness, augmentation index and trans thoracic echocardiography to assess left ventricular geometry, and systolic and diastolic function. Patients will undergo these measures at baseline (6- weeks prior to starting dialysis therapy), then at six and 12 months after starting dialysis. Discussion The results of this study may guide the choice of dialysis modality in the first year of treatment. It may also lead to a larger study prospectively assessing the effect of dialysis modality on cardiovascular morbidity and mortality. Trial Registration ACTRN12609000049279